Dose intensity phase I/II trial with carboplatin, ifosfamide, etoposide and vincristine combined with filgrastim in patients with small-cell lung cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/9260596

Download in:

View as

General Info

PMID
9260596